Automated External Defibrillator Market is Segmented By Analysis Type (Semi-automated External Defibrillators, Fully-automated External Defibrillators), By End-User(Hospitals/Clinics, Home Care, Others End-user), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Automated External Defibrillator Market Report Overview
The Automated External Defibrillator (AED) Market report analyzes the market size, current trends, competitive landscape, and future market outlook. The demand for Automated External Defibrillators is increasing due to the rising prevalence of cardiac disorders, and the availability of advanced AED devices with enhanced features. The market is witnessing significant growth in Europe and the Asia-Pacific region. The competitive rivalry is intensifying with major players such as Philips Healthcare, Stryker Corporation, Zoll Medical Corporation and others actively operating in the market.
An automated external defibrillator (AED) is a lightweight, portable device that delivers an electric shock from the chest to the heart. The shock can stop an irregular heartbeat and allow a normal rhythm to resume following a sudden cardiac arrest (SCA).
Automated External Defibrillator Market Scope and Summary
|
Metrics |
Details |
|
Market CAGR |
5.1% |
|
Segments Covered |
By Analysis Type, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Get a Free Sample Click here
Automated External Defibrillator Market Dynamics and Trends
The global automated external defibrillator market growth is driven by the rising prevalence of cardiac diseases, the increasing geriatric population, and technological advancements in the field supported by the increasing investment by the market players.
Technological advancements coupled with the rising prevalence of cardiac disease are expected to drive growth in the forecast period
The burden of cardiac diseases is growing with the prevailing sedentary lifestyle and the growing geriatric population worldwide. For example, the Journal of Cardiovascular Development and Disease article titled "Cardiovascular Risks Associated with Gender, and Aging," published in April 2019, reported that the aging and elderly population are particularly susceptible to cardiovascular diseases.
In addition, it also reported that risk factors closely associated with advanced age, such as frailty, obesity, and diabetes, have been shown to compound risks of cardiovascular disease. Such studies demonstrate that the chances of cardiovascular diseases increase with age.
Moreover, as per the Australian Government, Australia Institute of Health and Welfare article titled "Heart, stroke and vascular disease—Australian facts" updated in September 2021 reported that in the year 2019, cardiovascular diseases were the underlying cause of death in Australia and accounts 42,300 deaths which are nearly 25% of all deaths in Australia. Such a high burden of deaths generates a need for automated external defibrillators, thus driving the market's growth.
Additionally, the technological advancement in the field and the launch of new products by the market players boost the market's growth. For example, in July 2020, ZOLL Medical Corporation (Asahi Kasei Group company) launched its new remote view technology on the X Series monitor/defibrillator developed for EMS agencies.
Lack of cybersecurity and early corrective measures for sudden cardiac arrest (SAC) is likely to hinder the market growth
However, the factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the studied market over the forecast period. Moreover, Cybersecurity is another major concern in the defibrillators market. The new generation of implantable defibrillators is technologically advanced, allowing for remote data transfer. The FDA has raised concerns regarding the hacking of these devices. Medtronic was the latest company to face an FDA cybersecurity issue in 2019, as Medtronic’s wireless telemetry technology did not have encryption or authentication safety.
COVID-19 Impact on Automated External Defibrillator Market Growth
The COVID-19 pandemic adversely affected the economy in 2020 and presented various challenges to clinical healthcare providers and patients across the globe. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities & pre-existing conditions, and further protecting the public & hospital frontline workers from COVID-19 are major challenges healthcare systems face across the globe.
The pandemic has also impacted the buying capacity of hospitals, especially small-scale hospitals, resulting in canceled or postponed supply deals, which has impacted the overall revenue of all the major players in the defibrillators market. Also, due to lockdowns, many people lost their jobs and livelihood, which, in turn, affected the buying pattern of patients considerably.
Arrhythmias were observed in many COVID patients, but in-hospital defibrillator facilities helped save their lives. Due to the virus outbreak, many surgical procedures were canceled or postponed, depending on the criticality of the patient. This resulted in losses for companies.
COVID-19 also impacted various stages of the value chain, primarily due to strict lockdowns imposed by the governments of most countries. The turnaround time for the delivery of products and services was also affected due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market.
Automated External Defibrillator Market Segment and Shares
The semi-automatic defibrillators segment is expected to hold the largest share in this market segment
Semi-automatic defibrillators account for a majority share of the market. Easy usage due to clear voice prompts is a major reason for the popularity of semi-automatic defibrillators. Moreover, practitioners with minimal training can also use this device. For instance, on 12 September 2019, Mindray launched the BeneHeart C Series automated external defibrillator (AED) with smarter operations and faster shock delivery to achieve better resuscitation outcomes for sudden cardiac arrest (SCA). This new range is now available in Europe and other selected countries with both fully and semi-automatic versions.
Automated External Defibrillator Market Geographical Analysis
North America region holds the largest market share of the global automated external defibrillator market
The United States automated external defibrillators market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases, new product launches, and the emerging number of key market players in the region. For instance, according to the American Heart Association statistics published in January 2019, nearly half of Americans have some cardiovascular diseases, including hypertension, coronary heart disease, etc., which is expected to increase the burden of cardiovascular diseases in the country, driving the growth of the studied market.
American Heart Association’s Heart & Stroke Statistics - 2020 Update, over 356,000 out-of-hospital cardiac arrests occur in the United States each year, and nearly 90% of them are fatal. The estimated number of out-of-hospital cardiac arrests (OHCA) among adults in the United States is 347,322. Less than half (45.7%) of cardiac arrest victims get immediate help before emergency responders arrive in part because emergency medical services take, on average, between four and ten minutes to reach someone in cardiac arrest. However, if automated external defibrillators (AEDs) are available nearby, this high mortality from out-of-hospital cardiac arrests can be reduced, which may increase the demand for automated external defibrillators (AEDs) in the country, projecting growth of the studied market.
Automated External Defibrillator Companies and Competitive Landscape
The global automated external defibrillator market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Asahi Kasei Corporation, Koninklijke Philips NV, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Schiller AG, Stryker Corporation, CU Medical System Inc., Medina Co. Ltd, BPL Medical Technologies Pvt. Ltd, ViVest Medical, etc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market. For instance, in September 2021 - ZOLL MEDICAL introduced 3 Automated External Defibrillator (AED) models to penetrate the Thailand market. This estimated that demand for AEDs in Thailand would rise to 10,000 units.
Automated External Defibrillator Market – Key Companies to Watch
Nihon Kohden
Company Overview: Nihon Kohden Corporation, with branches in the United States, Europe, and Asia, is a leading Tokyo-based manufacturer, developer, and distributor of medical electronic equipment, including EEGs, EMG measurement devices, ECGs, patient tracking systems, and clinical information systems.
Product Portfolio: It includes products like Cardiolife AED-3100- Analysis of the heart rhythm and charging during CPR enables faster defibrillation delivery.
Key developments: March 2021 - As a part of the company’s three-year business plan, Nihon Kohden is expanding its United States business by integrating and unifying six local subsidiaries. Expanding its product line up in Neurology products, and treatment equipment such as next-generation automated chest compression devices.
Trending Topics
Plaque Modification Devices Market
Interventional Cardiology and Peripheral Vascular Devices Market
